Endo Savings and Investment Plan
Active. The plan filed its annual report for the 2023 plan year.
- Plan number
- 001Employer EIN 52-2035829
- Participants (2023)
- 3,307
- Net assets (2023)
- $492 million
- Recordkeeper
- SchwabEarlier: Principal (2009–2010)
- Plan administrator
- Endo USA, Inc.
1400 Atwater Drive
Malvern, PA 19355
(484) 216-0000As filed for 2023 - In effect since
- September 1, 1997
Plans merged into this one: Par Pharmaceutical, Inc. Retirement Savings Plan (2016); Ams Savings & Investment Plan (2012); Qualitest Pharmaceuticals 401(k) Plan (2011).
Earlier sponsors: Endo Pharmaceuticals Inc. (2009–2013); Endo Health Solutions Inc. (2014–2022); Endo Health Solution Inc. (2018).
Earlier plan names: Endo Pharmaceuticals Savings and Investment Plan.
Year by year, 2009 to 2023
| Plan year | Participants | Net assets | Recordkeeper |
|---|---|---|---|
| 2023 | 3,307 | $492 million | Schwab |
| 2022 | 3,560 | $434 million | Schwab |
| 2021 | 3,881 | $565 million | Schwab |
| 2020 | 3,978 | $517 million | Schwab |
| 2019 | 4,108 | $452 million | Schwab |
| 2018 | 4,261 | $381 million | Schwab |
| 2017 | 6,526 | $441 million | Schwab |
| 2016 | 4,117 | $294 million | Schwab |
| 2015 | 4,748 | $312 million | Schwab |
| 2014 | 5,169 | $357 million | Schwab |
| 2013 | 5,055 | $375 million | Schwab |
| 2012 | 5,029 | $201 million | Schwab |
| 2011 | 2,247 | $143 million | Schwab |
| 2010 | 1,610 | $110 million | Principal |
| 2009 | 1,960 | $89.2 million | Principal |